BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7056162)

  • 1. [The place of lymphoscintigraphy in the treatment of malignant melanoma of the skin (author's transl)].
    Munz DL; Altmeyer P; Holzmann H; Encke A; Hör G
    Dtsch Med Wochenschr; 1982 Jan; 107(3):86-91. PubMed ID: 7056162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk.
    Wanebo HJ; Harpole D; Teates CD
    Cancer; 1985 Mar; 55(6):1403-13. PubMed ID: 3971311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of lymphatic drainage basins in patients with cutaneous melanoma.
    Norman J; Wells K; Kearney R; Cruse CW; Berman C; Reintgen D
    Semin Surg Oncol; 1993; 9(3):224-7. PubMed ID: 8516608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoscintigraphy in malignant melanoma: 99mTc antimony sulfur colloid.
    Sullivan DC; Croker BP; Harris CC; Deery P; Seigler HF
    AJR Am J Roentgenol; 1981 Oct; 137(4):847-51. PubMed ID: 6974983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cutaneous lymphoscintigraphy in determining regional lymph node drainage of truncal melanomas.
    Fisher EB; Lewis VL; Griffith BH; Spies W
    Ann Plast Surg; 1992 Jun; 28(6):506-10. PubMed ID: 1622030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative cutaneous lymphoscintigraphy in malignant melanoma.
    Lock-Andersen J; Rossing N; Drzewiecki KT
    Cancer; 1989 Jan; 63(1):77-82. PubMed ID: 2910428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of intradermal lymphoscintigraphy on surgical management of clinical stage I truncal malignant melanoma.
    Kramer EL; Sanger JJ; Golomb F; Kopf AW; Postel A
    J Dermatol Surg Oncol; 1987 May; 13(5):508-15. PubMed ID: 3571689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic drainage to triangular intermuscular space lymph nodes in melanoma on the back.
    Uren RF; Howman-Giles R; Thompson JF; Quinn MJ; O'Brien C; Shaw HM; Bosch CM; McCarthy WH
    J Nucl Med; 1996 Jun; 37(6):964-6. PubMed ID: 8683322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium antimony sulfur colloid scintiscan in selective lymph node dissection for malignant melanoma.
    Doss LL; Padilla RS; Hladik WB
    J Dermatol Surg Oncol; 1986 Dec; 12(12):1280-4. PubMed ID: 3782601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary lymphoscintigraphy in breast cancer.
    Uren RF; Howman-Giles RB; Thompson JF; Malouf D; Ramsey-Stewart G; Niesche FW; Renwick SB
    J Nucl Med; 1995 Oct; 36(10):1775-80. PubMed ID: 7562041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expanding role of lymphoscintigraphy in the management of cutaneous melanoma. First Place Winner: Conrad Jobst award.
    Norman J; Cruse W; Ruas E; Beatty E; Hymes S; Espinosa C; Clark R; Reintgen D
    Am Surg; 1989 Dec; 55(12):689-94. PubMed ID: 2596765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma.
    Norman J; Cruse CW; Espinosa C; Cox C; Berman C; Clark R; Saba H; Wells K; Reintgen D
    Am J Surg; 1991 Nov; 162(5):432-7. PubMed ID: 1951904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphoscintigraphy in the study of lymphatic drainage patterns in patients with melanoma].
    Paradelo C; Fraile M; Ferrándiz C; Alastrué A; Bigatà X
    Med Clin (Barc); 1999 Sep; 113(8):281-4. PubMed ID: 10603579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoscintigraphy as a guide to treatment in malignant melanoma.
    Woods JE; Freedman AM; Brown ML
    Ann Plast Surg; 1989 Feb; 22(2):150-5. PubMed ID: 2735710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of cutaneous lymphatic flow rates in melanoma patients.
    Uren RF; Howman-Giles RB; Thompson JF; Roberts J; Bernard E
    Melanoma Res; 1998 Jun; 8(3):279-82. PubMed ID: 9664151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous lymphoscintigraphy in malignant melanoma.
    Bennett LR; Lago G
    Semin Nucl Med; 1983 Jan; 13(1):61-9. PubMed ID: 6836319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetry in lymphoscintigraphy of Tc-99m antimony sulfide colloid.
    Bergqvist L; Strand SE; Persson B; Hafström L; Jönsson PE
    J Nucl Med; 1982 Aug; 23(8):698-705. PubMed ID: 7108614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node.
    Uren RF; Howman-Giles RB; Shaw HM; Thompson JF; McCarthy WH
    J Nucl Med; 1993 Sep; 34(9):1435-40. PubMed ID: 8355060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to detect drainage to the popliteal and epitrochlear lymph nodes on cutaneous lymphoscintigraphy in melanoma patients.
    Uren RF; Howman-Giles RB; Thompson JF
    J Nucl Med; 1998 Dec; 39(12):2195. PubMed ID: 9867173
    [No Abstract]   [Full Text] [Related]  

  • 20. Scintigraphy of lymphatic vessels in malignant melanoma of the skin before operation (en bloc excision).
    Buchali K; Winter H; Blesin HJ; Schürer M; Sydow K
    Eur J Nucl Med; 1985; 11(2-3):88-9. PubMed ID: 4043120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.